Dividend Details

LYKA LABS LTD.

NSE : LYKALABSBSE : 500259ISIN CODE : INE933A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE129.253.8 (+3.03 %)
PREV CLOSE ( ) 125.45
OPEN PRICE ( ) 128.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25884
TODAY'S LOW / HIGH ( )125.70 134.40
52 WK LOW / HIGH ( )89 143.5
NSE128.803.05 (+2.43 %)
PREV CLOSE( ) 125.75
OPEN PRICE ( ) 128.40
BID PRICE (QTY) 128.80 (1040)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 473308
TODAY'S LOW / HIGH( ) 125.50 134.40
52 WK LOW / HIGH ( )88.5 144.3

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.